Characterization of Renal Allograft Rejection by Urinary Proteomic Analysis
- 1 May 2003
- journal article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 237 (5) , 660-665
- https://doi.org/10.1097/01.sla.0000064293.57770.42
Abstract
To develop a diagnostic method with no morbidity or mortality for the detection of acute renal transplant rejection. Rejection constitutes the major impediment to the success of transplantation. Currently available methods, including clinical presentation and biochemical organ function parameters, often fail to detect rejection until late stages of progression. Renal biopsies have associated morbidity and mortality and provide only a limited sample of the organ. Thirty-four urine samples were collected from 32 renal transplant patients at various stages posttransplantation. Samples were collected from 17 transplant recipients with acute rejection and 15 patients with no rejection. Samples from patients less than 4 days posttransplant were omitted from data analysis due to the presence of excessive inflammatory response proteins. Rejection status was confirmed by kidney biopsy. Specimens were analyzed in triplicate using SELDI mass spectrometry. The obtained spectra were subjected to bioinformatic analysis using ProPeak as well as CART (Classification and Regression Tree) algorithms to identify rejection biomarker candidates. These candidates were identified by their molecular weight and ranked by their ability to distinguish between nonrejection and rejection based on receiver operating characteristic (ROC) analysis. The candidates with the highest area under the ROC curve (AUC) exhibited the best diagnostic performance. The best candidate biomarkers demonstrated highly successful diagnostic performance: 6.5 kd (AUC = 0.839, P < .0001), 6.7 kd (AUC = 0.839, P < .0001), 6.6 kd (AUC = 0.807, P < .0001), 7.1 kd (AUC = 0.807, P < .0001), and 13.4 kd (AUC = 0.804, P < .0001). A separate analysis using the CART algorithm in the Ciphergen Biomarker Pattern Software correctly classified 91% of the 34 specimens in the training set, giving a sensitivity of 83% and specificity of 100% using two separate biomarker candidates at 10.0 kd and 3.4 kd. Biomarker candidates exist in urine that have the ability to distinguish between renal transplant patients with no rejection and those with acute rejection. These biomarker candidates are the basis for development of a noninvasive method of diagnosing acute rejection without the morbidity and mortality associated with needle biopsy. The combination of biomarkers into a panel for diagnosis leads to the possibility of enhanced diagnostic performance.Keywords
This publication has 25 references indexed in Scilit:
- SERIAL EVALUATION OF CELL SURFACE MARKERS FOR IMMUNE ACTIVATION AFTER ACUTE RENAL ALLOGRAFT REJECTION BY URINE FLOW CYTOMETRYTransplantation, 2001
- Noninvasive Diagnosis of Renal-Allograft Rejection by Measurement of Messenger RNA for Perforin and Granzyme B in UrineNew England Journal of Medicine, 2001
- Correlation of histology to clinical rejection reversal: A Thymoglobulin Multicenter Trial reportKidney International, 1999
- SAFETY OF KIDNEY BIOPSY IN PEDIATRIC TRANSPLANTATIONTransplantation, 1999
- Bactericidal Domain of Lactoferrin: Detection, Quantitation, and Characterization of Lactoferricin in Serum by SELDI Affinity Mass SpectrometryBiochemical and Biophysical Research Communications, 1998
- TACROLIMUS THERAPY FOR REFRACTORY ACUTE RENAL ALLOGRAFT REJECTIONTransplantation, 1996
- Dilemmas in renal transplantation: When the clinical course and histological findings differAmerican Journal of Kidney Diseases, 1996
- HISTOPATHOLOGICAL CONCORDANCE OF PAIRED RENAL ALLOGRAFT BIOPSY CORESTransplantation, 1995
- THE IMPACT OF ACUTE REJECTION EPISODES ON LONG-TERM GRAFT FUNCTION AND OUTCOME IN 1347 PRIMARY RENAL TRANSPLANTS TREATED BY 3 CYCLOSPORINE REGIMENSTransplantation, 1993
- THE INCIDENCE AND IMPACT OF EARLY REJECTION EPISODES ON GRAFT OUTCOME IN RECIPIENTS OF FIRST CADAVER KIDNEY TRANSPLANTSTransplantation, 1992